Shopping Cart
- Remove All
- Your shopping cart is currently empty
HPN-01 (IKK inhibitor XII) is a selective IKK inhibitor that inhibits IKK-α, IKK-β, and IKK-ε. HPN-01 reduces the severity of the disease, attenuates the immune imbalance, and prolongs the lifespan of mice in a model of autoimmune encephalomyelitis, and can be used to study immune disorders.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $317 | In Stock |
Description | HPN-01 (IKK inhibitor XII) is a selective IKK inhibitor that inhibits IKK-α, IKK-β, and IKK-ε. HPN-01 reduces the severity of the disease, attenuates the immune imbalance, and prolongs the lifespan of mice in a model of autoimmune encephalomyelitis, and can be used to study immune disorders. |
Targets&IC50 | IKKε:4.8(pIC50), IKKα:6.4(pIC50), IKKβ:7(pIC50), IKK1:6.4 (pIC50), IKK2:7 (pIC50), IKK-ε:4.8 (pIC50) |
In vitro | HPN-01 could inhibit the expression of SREBP-1 and SREBP-2 in human primary hepatocytes, and the IC50 values were 1.71 and 3.43, respectively. It is commonly used in the study of nonalcoholic fatty liver disease (NAFLD)[1]. |
Alias | HPN01, HPN 01 |
Molecular Weight | 401.87 |
Formula | C19H16ClN3O3S |
Cas No. | 928655-63-4 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (199.07 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.